Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1969 Dec;17(6):897-910.

A human serum immunoglobulin with specificity for certain homologous target cells, which induces target cell damage by normal human lymphocytes

A human serum immunoglobulin with specificity for certain homologous target cells, which induces target cell damage by normal human lymphocytes

I C MacLennan et al. Immunology. 1969 Dec.

Abstract

A factor has been found in a number of human sera which renders a polyploid strain of human liver cells, Chang cells, susceptible to damage by non-immune human lymphocytes. Sera possessing this factor are referred to as Factor Containing Sera (FCS). Such damage is assessed quantitatively by release of radioactive chromium from target cells. This factor has the chemical properties of IgG and can be absorbed out on Chang cells. Its specificity has been shown to be for Chang cells and not for human lymphocytes. Other homologous and heterologous target cells tested were not affected by this factor. The factor has not been shown to have any effect on Chang cell viability by itself, even in the presence of complement. Factors which inhibit target cell damage are shown to coexist with the factor which induces non-immune lymphocyte damage of Chang cells. The possible origin of this factor is discussed as is the role in immune reactions of target cell specific antibody which renders such cells susceptible to damage by non-immune lymphocytes.

PubMed Disclaimer

References

    1. Nature. 1965 Aug 21;207(999):818-21 - PubMed
    1. Prog Exp Tumor Res. 1965;6:289-322 - PubMed
    1. J Exp Med. 1967 Apr 1;125(4):721-36 - PubMed
    1. Immunology. 1967 May;12(5):525-36 - PubMed
    1. Immunology. 1967 Jun;12(6):675-87 - PubMed

LinkOut - more resources